The high adoption of technological advancement is one of the major driving factors for the growth of the global electrophysiology catheters market. Electrophysiology technology is advancing at a rapid pace along with the new ablation methods to enhance atrial fibrillation treatments, miniaturized diagnostic system and new implantable rhythm management devices which reduce procedure with less invasive. The technological development has prompted the introduction of new devices and products in the electrophysiology catheters market are expected to grow during the forecast period. For instance, in March 2017, Abbott Laboratories Inc. declared the US FDA approval for FlexAbility ablation catheter, sensor-enabled to increase the accuracy and versatility during cardiac ablation procedures and for the treatment of atrial flutter. Due to this approval, Abbott has widened its portfolio related to electrophysiology to effectively treat patients suffering from cardiac arrhythmias and supports physicians to solve complex cases.
A full report of Electrophysiology Catheters Market is available at: https://www.omrglobal.com/industry-reports/electrophysiology-catheters-market
Increasing demand of diagnostic catheters for early diseases diagnosis boost the market growth
The increasing demand for diagnostic catheters is one of the major driving factors that are fueling the growth of the electrophysiology catheters market. The prognosis of patients along with adult congenital heart diseases has enhanced significantly owing to early diagnosis and enhancement in surgical corrective techniques. ERG test is an effective method in observing the patient for early treatment. VEP can reveal early functional changes in amplitude which are undetectable through different other means. The technology can confirm a diagnosis that provides a practitioner to start treatment much earlier. VEP test is useful in determining asymmetry and early indicator of a number of conditions. Additionally, corneal hysteresis is not clear in one eye than full analysis with VEP test may discover changes in latency.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/electrophysiology-catheters-market
Moreover, the catheter is utilized to deliver low voltage and high-frequency current which destroy the heart tissue that is responsible for the arrhythmia. The patients who have done with the treatment of catheter ablation has experience of long term reduction in the number of arrhythmias and return to normal heart rhythm. The technology Carto 3 has provided three-dimensional views of the patient’s heart that enables the electrophysiologist to identify the origin of abnormal rhythm accurately and provide radio frequency catheter ablation with large rate. The different benefit of cardiac ablation therapy includes better quality of care, cost-effective and better quality of life. Thus, early treatment and diagnosis for catheters ablation are fueling the growth of the market.
In the economies of Asia-Pacific region, the healthcare systems are facing challenges such as the burden of increasing and aging population, delivery of adequate healthcare facility and low per capita income. The healthcare expenditure in these countries is growing significantly with the increasing interest from both private and public sectors. Economies of Asia-Pacific region such as China and India are amongst the fastest developing countries in the adoption and implementation of new technologies across the globe. Increasing diagnostic rate of diseases and increasing healthcare expenditure in these countries are anticipated to lead to increased demand for electrophysiology catheters during the forecast period.
Global electrophysiology catheters Market Segmentation
By Product Type
- Diagnostic Catheters
- Ablation Catheters
- Smart home display
By End-User
- Hospitals & Clinics
- Ambulatory Surgical Centers
